Mulmit

Compass Therapeutics, Inc.Compass Therapeutics, Inc.

CMPX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-72,839,000-66,489,000
2024-12-31850,000-56,625,000-49,375,000
2023-12-310-50,363,000-42,494,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-04-29Anderman JonathanGeneral Counsel25,000
2026-04-29Lerner NeilChief Accounting Officer15,000
2026-02-08Schuetz Thomas J.CHIEF EXECUTIVE OFFICER36,687
2026-01-09Schuetz Thomas J.CHIEF EXECUTIVE OFFICER46,777
2026-01-02Shin BarryCFO125,000
2026-01-02Shin BarryCFO670,000
2026-01-02Sirard CynthiaChief Medical Officer1,000,000
2026-01-02Schuetz Thomas J.CEO250,000
2026-01-02Schuetz Thomas J.CEO2,000,000
2026-01-02Prasad ArjunChief Commercial Officer1,000,000
2026-01-02LINDAHL RICHARD S90,000
2026-01-02Chiniara Ellen90,000

8-K events

FiledItems
2026-09-22Regulation FD disclosure · Financial statements and exhibits
2026-08-06Results of operations · Financial statements and exhibits
2026-07-01Regulation FD disclosure · Financial statements and exhibits
2026-06-23Amendments to charter or bylaws · Financial statements and exhibits
2026-06-11Submission of matters to a vote
2026-05-05Results of operations · Financial statements and exhibits
2026-04-27Regulation FD disclosure · Other events · Financial statements and exhibits
2026-03-05Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.